# The Feasibility of Sugammadex for General Anesthesia in Patients Undergoing Kidney and Pancreas Transplantation Surgery

> **NCT04944303** · NA · COMPLETED · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 52 (actual)

## Conditions studied

- Surgery

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04944303
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-18
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-04-21
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04944303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04944303, "The Feasibility of Sugammadex for General Anesthesia in Patients Undergoing Kidney and Pancreas Transplantation Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04944303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*